A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

Pegfilgrastim is a pegylated form of the granulocyte‐colony stimulating factor, filgrastim. Herein, we report the results of a multicentre, randomized, double‐blind phase III trial comparing the efficacy and safety of pegfilgrastim with filgrastim in patients with malignant lymphoma. Patients were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Kohmei, Miyazaki, Yasuhiko, Murayama, Tohru, Shimazaki, Ryutaro, Usui, Noriko, Urabe, Akio, Hotta, Tomomitsu, Tamura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074273/
https://www.ncbi.nlm.nih.gov/pubmed/27072050
http://dx.doi.org/10.1111/bjh.14088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074273/
https://www.ncbi.nlm.nih.gov/pubmed/27072050
http://dx.doi.org/10.1111/bjh.14088

Ejemplares similares